Cross-over study of muzolimine and hydrochlorothiazide-amiloride in hypertensive patients(630 views visite) Ferrara LA, Strazzullo P, Scillitani A, Mancini M, Gagliardi R
Keywords Parole chiave: Antihypertensive Treatment, Hydrochlorothiazide + Amiloride, Hypertensive Patients, Muzolimine, Serum Potassium, Side-Effects, Hypertensive Agent, New Drug, Placebo, Adverse Drug Reaction, Blood Pressure, Cardiovascular System, Clinical Trial, Controlled Study, Drug Comparison, Drug Efficacy, Drug Therapy, Drug Tolerance, Human, Human Experiment, Methodology, Oral Drug Administration, Potassium Blood Level, Priority Journal, Adult, Drug Combinations, Female, Lipids, Middle Aged, Pyrazines, Pyrazoles,
Affiliations Affiliazioni: Institute of Internal Medicine and Metabolic Diseases, 2nd Medical School, University of Naples, Italy Medical Department, Bayer Italia S.p.A., Italy
References Riferimenti: Not available. Non disponibili.
Cross-over study of muzolimine and hydrochlorothiazide-amiloride in hypertensive patients
20 Records (15 escludendo Abstract e Conferenze). Impact factor totale: 46.861 (43.688 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 52.171 (48.988 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Massimiliano Sorbillo on in data Sunday 12 July 2020, 13:15:17 630 views visite. Last view on Ultima visita in data Wednesday 20 January 2021, 18:00:56